Similar articles

• Antifibrinolytics.

  Schmarts. Schmarts. Acta Anaesthesiol Belg. 2003;54(4):319-22. Acta Anaesthesiol Belg. 2003. PMID: 14719353 Review. No abstract available.
• Current antifibrinolytic therapy for coronary artery revascularization.

  Trudell J, McMurdy N. Trudell J, et al. AANA J. 2008 Apr;76(2):121-4. AANA J. 2008. PMID: 18478817 Review.
• Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.

  Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, Cossolini M, Torri G, Calori G, Benussi S, Alfieri O. Casati V, et al. J Thorac Cardiovasc Surg. 2000 Sep;120(3):520-7. doi: 10.1067/mtc.2000.108016. J Thorac Cardiovasc Surg. 2000. PMID: 10962414 Clinical Trial.
• The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.

  Mengistu AM, Röhm KD, Boldt J, Mayer J, Suttner SW, Piper SN. Mengistu AM, et al. Anesth Analg. 2008 Aug;107(2):391-7. doi: 10.1213/ane.0b013e31817b7732. Anesth Analg. 2008. Retraction in: Anesth Analg. 2011 May;112(5):1081. doi: 10.1213/ANE.0b013e31821a8fd2. PMID: 18633013 Retracted. Clinical Trial.
• Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.

  Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ. Later AF, et al. Eur J Cardiothorac Surg. 2009 Aug;36(2):322-9. doi: 10.1016/j.ejcts.2008.11.038. Epub 2009 Feb 27. Eur J Cardiothorac Surg. 2009. PMID: 19250838 Clinical Trial.